Inmunova S.A

Inmunova is company based on early discoveries from Dr. Fernando Goldbaums Laboratory at Fundacion Instituto Leloir. Its core technology is a proprietary platform, called Immuno Multi Carrier (IMC), which allows the design of state-of-the-art recombinant vaccines and immunomodulators. Patents for these technologies have been granted (IMC) or filed (IMC-Stx) in USA, Canada, EU, Japan, China, India, Brazil, Mexico and Argentina

Inmunova s.a operates in the Biotechnology research industry.

Inmunova s.a's revenue is 11m - 100m

Inmunova s.a has 11 - 50 employees.